¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"idiopathic systemic fibrosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
¿µ¹® cystic fibrosis ÇÑ±Û ³¶¼º¼¶À¯Áõ
¼³¸í   
  À¯Àüº´ÀÇ Çϳª·Î ¶¡»ù, ±â°üÁö¿¡¼­ Á¡¾×À» ºÐºñÇϴ »ù, ÀÌÀÚµîÀÇ ¿ÜºÐºñ»ù(¸ö ¹ÛÀ¸·Î ¾×ü¸¦ ºÐºñÇϴ »ù. ³»ºÐºñ»ùÀ» Á¦¿ÜÇÑ ¸ðµç »ùÀ» À̸¥´Ù)ÀÇ ÀÌ»óÀ» Æ¯Â¡À¸·Î Çϴ º´ÀÌ´Ù. Áß¿äÇÑ º´ÀûÀΠº¯È­´Â ÁַΠ±â°üÁö¿¡¼­ Á¡¾×À» ºÐºñÇϴ ºÐºñ»ù¿¡¼­ Áö³ªÄ¡°Ô Á¡µµ°¡ ³ôÀº Á¡¾×ÀÌ ºÐºñµÇ¾î ±â°üÁö¸¦ ¸·¾Æ È£ÈíÀå¾Ö¸¦ ÀÏÀ¸Å°´Â ÆóÀÇ º´ÅÍÀ̸ç, ¶¡¿¡¼­ °úµµÇÑ ÀüÇØÁú Æ¯È÷ ¿°È­³ªÆ®·ý(NaCl)ÀÌ ºÐºñµÇ¾î ¸ö¿¡ ÀüÇØÁúÀÌ ºÎÁ·ÇϰԠµÈ´Ù. ¶Ç ÀÌÀÚÀÇ ¼ÒÈ­¾×À» ºÐºñÇϴ ºÐºñ»ùÀÇ ÀÌ»óÀ¸·Î ÀÌÀÚ°üÀÌ ¸·È÷°Å³ª ÀÌÀÚÀÇ ±â´ÉÀÌ ¶³¾îÁ®¼­ ¼ÒÈ­ÀÇ Àå¾Ö¸¦ ÀÏÀ¸Å°±âµµ ÇÑ´Ù. À¯Å°迡 ¸¹À¸¸ç ¿ì¸®³ª¶ó¿¡´Â ¾ÆÁÖ µå¹°´Ù.
¿µ¹® fibrosis ÇÑ±Û ¼¶À¯Áõ, ¼¶À¯È­
¼³¸í   
  ¾Æ±³Áú¼¶À¯¸¦ Çü¼ºÇϴ ¼¶À¯Á¶Á÷ÀÇ Áõ½ÄÀ¸·Î ¸öÀÇ ½ÇÁú¼¼Æ÷ÀÇ ±«»ç³ª ¼Õ»ó¿¡ À̾ ³ªÅ¸³ª´Â °æ¿ì°¡ º¸ÅëÀÌ´Ù. µÎ ´Ü°è, Áï ¼Õ»óºÎÀ§¿¡¼­ ¼¶À¯¸ð¼¼Æ÷ÀÇ ÀÌÁÖ¿Í Áõ½Ä, ±×¸®°í ¼¶À¯¸ð¼¼Æ÷¿¡ ÀÇÇÑ ¼¼Æ÷ÀÇ ¹ÙÅÁÁú ÃàÀûÀ¸·Î ÁøÇàµÈ´Ù. ÇǺÎÀÇ °æ¿ì ÁøÇdz» ¼¶À¯¸ð¼¼Æ÷ÀÇ Áõ½Ä°ú ¾Æ±³Áú ¼¶À¯ÀÇ Áõ½ÄÀÌ Àִ °æ¿ì¸¦ ¼¶À¯È­, °ÅÀÇ ¾Æ±³Áú ¼¶À¯·Î¸¸ ±¸¼ºµÇ´Â °æ¿ì¸¦ °æÈ­¶ó°í ÇÑ´Ù.
¿µ¹® systemic lupus erythematosus ÇÑ±Û Àü½ÅÈ«¹Ý·çǪ½º
¼³¸í   
  Àü½Å ÀÚ°¡¸é¿ªº´ÀÇ ´ëÇ¥Àû º´ÀÌ´Ù. ¿©¼º¿¡°Ô ¾ÐµµÀûÀ¸·Î ¸¹°í, 10~39¼¼±îÁö°¡ 70%¸¦ Â÷ÁöÇÑ´Ù. ¿øÀÎÀº Àß ¸ð¸£³ª ÀÚ°¡¸é¿ª Á¶Àý±â´É¿¡ Àå¾Ö°¡ Àִ °ÍÀ¸·Î »ý°¢µÈ´Ù. À¯Àü¿äÀÎ, È£¸£¸óÀÇ ¿µÇâ, È¯°æ¿ä¼Ò°¡ Á¾ÇÕÀûÀ¸·Î º¸Á¶ T¼¼Æ÷¿Í B¼¼Æ÷¸¦ È°¼ºÈ­½ÃÄѼ­ ¿©·¯ °¡Áö ÀÚ°¡Ç×üµé, Áï Ãµ¿¬ DNA, ÀÌÁß°¡´Ú DNA, ¿Ü°¡´Ú DNA, RNA, ÇٴܹéÁú µî°ú °°Àº ÇÙ Ç׿ø¿¡ ´ëÇÑ Ç×ü, ºñÇÙÇ׿ø¿¡ ´ëÇÑ ¿©·¯ °¡Áö Ç×ü°¡ ½ñ¾ÆÁ® ³ª¿Â´Ù. ÀÌ Áß ÀÌÁß°¡´Ú DNA¸¦ Æ÷ÇÔÇÑ ¼øÈ¯¸é¿ªº¹ÇÕü°¡ ÄáÆÏ¿¡ Ä§ÂøÇÏ¿© ¼Õ»óÀ» ÀÏÀ¸Å°´Âµ¥ °ü¿©ÇÑ´Ù. DNA¿Í ¿©·¯ °¡Áö ¼¼Æ÷¼ººÐ¿¡ ´ëÇÑ ÀÚ°¡¸é¿ªÁúȯÀ¸·Î ÀüÄáÆÏ±â¸¦ Ä§¹üÇÏ¿© ¿°ÁõÀ» ÀÏÀ¸Å²´Ù. ¿©·¯ ÀÚ°¡Ç׿ø¿¡ ´ëÇÑ ¸é¿ª¹ÝÀÀ¿¡ ÀÇÇÑ Ç×üÀÇÁ¸¼º ¸é¿ª¹ÝÀÀ°ú ¸é¿ªº¹ÇÕü ¹ÝÀÀÀ¸·Î Å丮ÄáÆÏ¿°, Ç÷°ü¿°, °üÀý¿° ¹× ºóÇ÷À» µ¿¹ÝÇÑ´Ù.
¿µ¹® systemic circulation ÇÑ±Û Ã¼¼øÈ¯
¼³¸í   
  ¿Þ½É½Ç¿¡¼­ ½Åü¸¦ µ¹¾Æ ¿À¸¥½É¹æ±îÁöÀÇ ¼øÈ¯À» ÀǹÌÇϸç, ¿Þ½É½Ç ¡æ ´ëµ¿¸Æ ¡æ µ¿¸Æ ¡æ ¸ð¼¼Ç÷°ü ¡æ Á¤¸Æ ¡æ ´ëÁ¤¸Æ ¡æ ¿À¸¥½É¹æÀǠȸ·Î¸¦ ¼øÈ¯ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • idiopathic systemic fibrosis
    Ư¹ßÀü½Å¼¶À¯Áõ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • idiopathic pulmonary fibrosis
    Ư¹ßÆó¼¶À¯Áõ
  • circumscribed fibrosis
    ±¹ÇѼ¶À¯Áõ
  • cortical stromal fibrosis
    °ÑÁú¹ÙÅÁÁú¼¶À¯Áõ, ÇÇÁú±âÁú¼¶À¯Áõ
  • cystic fibrosis
    ³¶¼º¼¶À¯Áõ
  • endomyocardial fibrosis
    ½É³»¸·½É±Ù¼¶À¯Áõ
  • fibrosis
    1. ¼¶À¯Áõ 2. ¼¶À¯È­
  • interstitial fibrosis
    1. »çÀÌÁú¼¶À¯È­ 2. °£Áú¼¶À¯Áõ
  • mediastinal fibrosis
    Á¾°Ý¼¶À¯Áõ, ¼¼·ÎÄ­¼¶À¯Áõ
  • neoplastic fibrosis
    Á¾¾ç¼º¼¶À¯È­
  • postfibrinous fibrosis
    ¼¶À¯¼ÒÄ§ÂøÈļ¶À¯È­, ÇÇºê¸°Ä§ÂøÈļ¶À¯È­
  • periductal fibrosis
    °üÁÖÀ§¼¶À¯Áõ
  • reactive fibrosis
    ¹ÝÀÀ¼¶À¯È­
  • replacement fibrosis
    ´ëÄ¡¼¶À¯È­
  • subepidermal nodular fibrosis
    Ç¥ÇǹذáÀý¼¶À¯Áõ
  • submucous fibrosis
    Á¡¸·¹Ø¼¶À¯Áõ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • idiopathic pulmonary fibrosis
    Ư¹ß¼ºÆó¼¶À¯Áõ
  • idiopathic crescentic glomerulonephritis
    Ư¹ßÃʽ´ÞÅ丮ÄáÆÏ¿°, Ư¹ßÃʽ´޻籸ü½Å¿°
  • acute idiopathic polyneuritis
    ±Þ¼ºÆ¯¹ß¿©·¯½Å°æ¿°, ±Þ¼ºÆ¯¹ß´Ù¹ß½Å°æ¿°
  • fibrosis
    ¼¶À¯Áõ, ¼¶À¯È­
  • annulus fibrosis
    ¼¶À¯Å×
  • interstitial fibrosis
    »çÀÌÁú¼¶À¯Áõ, »çÀÌÁú¼¶À¯È­
  • systemic circulation
    ¿Â¸ö¼øÈ¯, ü¼øÈ¯
  • systemic disease
    Àü½Åº´
  • systemic embolism
    Àü½Å»öÀüÁõ
  • systemic hypotension
    Àü½ÅÀúÇ÷¾Ð
  • systemic infection
    Àü½Å°¨¿°
  • systemic erythematosus lupus
    Àü½ÅÈ«¹Ý·çǪ½º
  • systemic reaction
    Àü½Å¹ÝÀÀ
  • systemic sclerosis
    Àü½Å°æÈ­Áõ
  • systemic inflammatory response syndrome
    Àü½Å¿°Áõ¹ÝÀÀÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • idiopathic systemic fibrosis
    Ư¹ßÀü½Å¼¶À¯Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • arteriocapillary fibrosis
    µ¿¸Æ¸ð¼¼Ç÷°ü¼¶À¯Áõ
  • circumscribed fibrosis
    ºÎºÐ¼¶À¯Áõ
  • cortical stromal fibrosis
    °ÑÁú¹ÙÅÁÁú¼¶À¯Áõ, ÇÇÁú±âÁú¼¶À¯Áõ
  • fibrosis
    ¼¶À¯Áõ, ¼¶À¯È­
  • neoplastic fibrosis
    Á¾¾ç¼¶À¯Áõ
  • periductal fibrosis
    ´ã°üÁÖÀ§¼¶À¯Áõ, ¾µ°³°üÁÖÀ§¼¶À¯Áõ
  • postfibrinous fibrosis
    ¼¶À¯¼ÒÈļ¶À¯Áõ
  • reactive fibrosis
    ¹ÝÀÀ¼¶À¯Áõ
  • replacement fibrosis
    ´ëÄ¡¼¶À¯Áõ
  • sclerosing fibrosis
    °æÈ­¼¶À¯Áõ
  • subepidermal nodular fibrosis
    Ç¥ÇǹذáÀý¼¶À¯Áõ
  • submucous fibrosis
    Á¡¸·¹Ø¼¶À¯Áõ
  • systemic amyloidosis
    Àü½Å¾Æ¹Ð·ÎÀ̵åÁõ
  • systemic arachnidism
    Àü½Å°Å¹Ìµ¶Áõ
  • bullous systemic l. erythematosusv lupus
    ¹°ÁýÀü½ÅÈ«¹Ý·çÇÁ½º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • idiopathic systemic fibrosis
    Àü½Å¼º Ư¹ß¼º(îïãóàõ ÷åÛ¡àõ) ¼¶À¯Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • idiopathic pulmonary fibrosis
    Ư¹ß¼º Æó¼¶À¯È­Áõ(¡­øËàéë«ûùñø)
  • Lupus erythematosus(LE), systemic
    Àü½Å¼ºÈ«¹Ý¼º ·çǪ½º.
  • SLE= systemic lupus erythematosus
    Àü½Å¼º È«¹Ý¼º ·çǪ½º.
  • acute systemic lupus erythematosus = ASLE
    ±Þ¼º Àü½Å¼º È«¹Ý¼º ³¶Ã¢(¡­îïãóàõûõÚèàõÕÉóê)
  • acute systemic lupus erythematosus =ASLE
    ±Þ¼º Àü½Å¼º È«¹Ý¼º ³¶Ã¢(¡­îïãóàõûõÚèàõÕÉóê).
  • anomalies of systemic venous return
    ´ëÁ¤¸ÆÈ¯·ù(ÓÞð¡Øæü½êü)ÀÌ»ó.
  • anomalies of systemic venous return
    ´ëÁ¤¸ÆÈ¯·ù(ËÀ?ËÎÌ·Ëô)ÀÌ»ó.
  • infantile systemic hyalinosis
    ¿µ¾Æ Àü½Å¼º À¯¸®ÁúÁõ
  • infection, systemic
    Àü½Å°¨¿°
  • portal-systemic encephlopathy
    ¹®¸Æ-Àü½Å¼øÈ¯¼º ³úº´Áõ(Ú¦Øæ-îïãóâàü»àõ ÒàÜ»ñø)
  • porto-systemic shunt
    ¹®¸ÆÃ¼´Ü¶ô(Ó­Õ©)<--¼ÇÆ®>
  • primary systemic amyloidosis
    ¿ø¹ß¼º Àü½Å À¯ÀüºÐÁõ
  • progressive systemic sclerosis
    ÁøÇ༺ Àü½Å °æÈ­Áõ
  • progressive systemic sclerosis
    ÁøÇ༺ Àü½Å¼º °æÈ­Áõ(Ìãûùñø)
  • progressive systemic sclerosis
    ÁøÇà(¼º) Àü½Å°æÈ­Áõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • idiopathic systemic fibrosis
    Àü½Å¼º Ư¹ß¼º(îïãóàõ ÷åÛ¡àõ) ¼¶À¯Áõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • idiopathic diffuse intersitial fibrosis of lung
  • idiopathic pulmonary fibrosis
    Ư¹ß¼º Æó¼¶À¯È­Áõ(¡­øËàéë«ûùñø)
  • arteriocapillary fibrosis
    µ¿¸Æ¸ð¼¼Ç÷°ü¼¶À¯Áõ(¡­Ù¾á¬úìηàéë«ñø).
  • circumscribed fibrosis
    ±¹ÇѼº ¼¶À¯Áõ
  • congenital fibrosis syndrome
    ¼±Ãµ¼¶À¯ÁõÁõÈıº
  • congenital hepatic fibrosis
    ¼±Ãµ¼º °£¼¶À¯Áõ(¡­ÊÜàéë«ñø).
  • corporal fibrosis
    (À½°æÇظé)ü ¼¶À¯Áõ(È­)
  • cortical stromal fibrosis
    ÇÇÁú°£Áú¼¶À¯È­(¡­Êàòõàéë«ûù)
  • cystic fibrosis
    ³¶¼º¼¶À¯Áõ(¡­àéë«ñø).
  • cystic fibrosis
    ³¶¼º¼¶À¯Áõ
  • cystic fibrosis
    ³¶¼º¼¶À¯Áõ(¡­àéë«ñø)
  • cystic fibrosis of pancreas
    ÃéÀå³¶¼º¼¶À¯Áõ(õýíôÒ¥àõàéë«ñø).
  • diffuse interstitial pulmonary fibrosis
    ¹Ì¸¸¼º °£Áú¼º Æó¼¶À¯Áõ.
  • endocardial fibrosis
    ½É³»¸·¼¶À¯Áõ.
  • endomyocardial fibrosis
    ½É³»¸·½É±Ù¼¶À¯Áõ.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Fibrosis
    ¼¶À¯È­
    [¿¾ ¿ë¾î] ¼¶À¯È­
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Symmer's pipestem fibrosis
    ½Ã¸ÓÆÄÀÌÇÁ¼¶À¯È­
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • idiopathic pentosuria
    Ư¹ß¼º(÷åÛ¡àõ) ÆæÅ佺´¢Áõ(Òãñø)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • idiopathic retroperitoneal fibrosis
    Ư¹ß¼ºÈĺ¹¸·°­¼¶À¯Áõ
  • systemic
    Àü½Å¼ºÀÇ
  • systemic blood pressure
    üÇ÷¾Ð
  • systemic infection
    Àü½Å¼º°¨¿°(Áõ)
  • systemic lesion
    Àü½Å¼ºº´º¯
  • systemic lupus erythematosus
    Àü½Å¼ºÈ«¹Ý¼º·çǪ½º
  • idiopathic
    Ư¹ß¼ºÀÇ
  • idiopathic hypertrophic osteoarthropathy
    Ư¹ß¼º°úÇü¼º°ñ°üÀýº´Áõ
  • idiopathic respiratory distress syndrome
    Ư¹ß¼ºÈ£Èí°ï¶õÁõÈıº
  • idiopathic thrombocytopenic purpura
    Ư¹ß¼ºÇ÷¼ÒÆÇ °¨¼Ò¼º Àڹݺ´
  • idiopathic unilateral hyperlucent lung
    Ư¹ß¼ºÀÏÃø¼º°úÅõ°ú¼ºÆó
  • cystic fibrosis
    ³¶¼º¼¶À¯Á¾
  • fibrosis
    ¼¶À¯Áõ, ¼¶À¯È­
  • myocardial fibrosis
    ½É±Ù¼¶À¯Áõ
  • pancreatic cystic fibrosis
    ÃéÀå³¶¼º¼¶À¯Áõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MF   1) Myelo-Fibrosis
    = Agnogenic Myeloid Metaplasia with Myelo-F...
IPF idiopathic pulmonary fibrosis; infection-potentiating factor; interstitial pulmonary fibrosis
CFF critical flicker fusion [test]; critical fusion frequency; cystic fibrosis factor; Cystic Fibrosis F...
CFP chronic false positive; Clinical Fellowship Program; cyclophosphamide, fluorouracil, prednisone; cys...
IPH idiopathic portal hypertension; idiopathic pulmonary hemosiderosis; idiopathic pulmonary hypertensio...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IRF Idiopathic Retroperitoneal Fibrosis
IPF Idiopathic pulmonary fibrosis
CHF Congenital hepatic fibrosis
CF cvstic fibrosis
CFTR Cystic Fibrosis Transmembrane Conductance Regulator
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • congenital fibrosis syndrome
    ¼±Ãµ ¼¶À¯Áõ ÁõÈıº
  • cystic fibrosis
    ³¶¼º ¼¶À¯Áõ, ³¶Æ÷¼º ¼¶À¯Áõ, ³¶Æ÷¼º ¼¶À¯È­Áõ
  • endomyocardial fibrosis
    ½É³»¸· ¼¶À¯Áõ
    ±×¸® ¸¹Áö ¾ÊÀº ÁúȯÀ¸·Î ÁÖ·Î Á½ɽÇÀÇ ½É³»¸·¿¡ ±¹¼ÒÀû ¶Ç´Â ¹Ì¸¸¼ºÀÇ ¼¶À¯ ź·Â¼º ºñÈĸ¦ °¡Á®¿Â´Ù. ¾î´À ³ªÀÌ¿¡³ª ¿Ã ¼ö ÀÖÀ¸³ª µÎ »ì ÀÌÇÏÀÇ ¾î¸°ÀÌ¿¡¼­ ¸¹ÀÌ ¹ß»ýÇÑ´Ù. ´ëºÎºÐ »ê¹ßÀûÀ¸·Î ¹ß»ýÇÏ¸ç ¼±ÃµÀû ½ÉÀå ±âÇüÀÌ ¾à 1/3¿¡¼­ ³ªÅ¸³­´Ù. ¿øÀÎÀ¸·Î »ý°¢µÇ´Â °ÍÀº Àú»ê¼ÒÁõ, ¸¸¼ºÀûÀÎ ¾Ð·Â°ú´Ù, ¿ø¹ß¼º ½É±Ù ´ë»çÀå¾Ö, ÀÚ°¡¸é¿ª¼º Áúȯ, ¼±ÃµÀûÀÎ ±âÇü, ¸²ÇÁ°ü Æó¼â, žÆÀÇ ½É³»¸·¿° µîÀÌ´Ù. ÁÂ½É½Ç ºñÈÄ ¶Ç´Â È®Àå ¶§¹®¿¡ ½ÉÀå °Å´ëÁõÀÌ ¿À¸ç ¶§·Î ´ëµ¿¸ÆÆÇ ¶Ç´Â ½Â¸ðÆÇ ÇùÂøÁõÀÌ °üÂûµÈ´Ù.
  • hyaline fibrosis
    À¯¸®Áú ¼¶À¯Áõ
  • ostitis fibrosis cystica
    ³¶Á¾ ¼¶À¯¼º °ñ¿°
  • radiation fibrosis of lung
    ¹æ»ç¼± Æó ¼¶À¯Áõ
  • retroperitoneal fibrosis
    º¹¸·ÈÄ ¼¶À¯Áõ
  • subepidermal nodular fibrosis
    Ç¥ÇÇÇÏ °áÀý¼º ¼¶À¯Áõ
  • acute idiopathic thrombocytopenic purpura
    ±Þ¼º Ư¹ß¼º Ç÷¼ÒÆÇ °¨¼Ò¼º ÀÚ¹Ý º´
  • agnogenic idiopathic myeloid metaplasia
    ¿øÀÎ ºÒ¸í Ư¹ß¼º °ñ¼ö È­»ýÁõ
  • chronic idiopathic megacolon
    ¸¸¼º Ư¹ß¼º °Å´ë °áÀå, ¸¸¼º Ư¹ß¼º °Å´ë °áÀåÁõ
  • idiopathic abortion
    Ư¹ß¼º À¯»ê
    ±âÁúÀûÀÎ ¿øÀÎÀÌ ¾øÀÌ ³ªÅ¸³ª´Â À¯»ê.
  • idiopathic cyclic neutropenia
    Ư¹ß¼º Áֱ⼺ È£Áß±¸ °¨¼ÒÁõ
    ¸¸¼ºÇüÀÇ È£Áß±¸ °¨¼ÒÁõÀ¸·Î¼­, ÁÖ±âÀûÀ¸·Î ÀϾ´Â Àç¹ßÀ» Ư¡À¸·Î Çϸç, º´°¨, ¹ß¿­, ±¸³»¿° ¹× °¢Á¾ÀÇ °¨¿°À» µ¿¹ÝÇÑ´Ù.
  • idiopathic disease
    Ư¹ßº´
    ´Ù¸¥ ÁúȯÀÇ °á°ú·Î ¹ß»ýÇÏÁö ¾Ê´Â Áúº´À¸·Î¼­, ¿øÀÎÀº ºÒ¸íÀÌ´Ù.
  • idiopathic fibrous gingival hyperplasia
    Ư¹ß¼º ¼¶À¯¼º Ä¡Àº Áõ½Ä
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
idiopathic interstitial fibrosis A progressive inflammatory condition starting with diffuse alveolar damage and resulting in fibrosis and honeycombing over a variable time period; also a common feature of collagen-vascular diseases.
Synonym: fibrosing alveolitis, Hamman-Rich syndrome, idiopathic interstitial fibrosis.
(05 Mar 2000)
idiopathic pulmonary fibrosis <radiology> Aka: usual interstitial pneumonia (UIP), 5-6th decade; M:F = 1:1, clubbing of fingers (83%), lymphocytosis on lavage, increased occurence of bronchogenic CA, average survival of 4-6 years; 87% mortality CXR findings: occasional ground glass pattern in early stage of alveolitis, diffuse reticulations (60%) predominantly at bases, honeycombing, pleural effusion (4%); pleural thickening (6%), pneumothorax in 7% (late stage), progressive volume loss see: interstitial pulmonary fibrosis
(12 Dec 1998)
African endomyocardial fibrosis Fibrosis of the inner layers of the myocardium, often including the endocardium, causing diastolic restriction of the heart; indigenous to East Africa.
(05 Mar 2000)
radiation fibrosis The formation of scar tissue as a result of radiation therapy to the lung.
(12 Dec 1998)
mediastinal fibrosis <radiology> Histoplasmosis most common cause, can cause superior vena cava obstruction
(12 Dec 1998)
replacement fibrosis The formation of fibrous tissue that occupies sites where various other cells and tissues have become atrophied, or degenerated and necrotic.
(05 Mar 2000)
retroperitoneal fibrosis <radiology> Ureters tapered or obstructed, most severe at L4-5, ureters deviated medially, Treatment: symptomatic; steroids have ? long-term benefit Differential diagnosis: malignancy, lymphoma (especially Hodgkin's), metastasis from colon and breast, retroperitoneal sarcoma, drugs, methysergide (Sansert), haemorrhage, aortic aneurysm, trauma or surgery, inflammation, Crohn's disease, diverticulitis, pancreatitis, extravasated urine, radiation
(12 Dec 1998)
pericentral fibrosis Fibrosis occurring around the central veins in the hepatic lobules.
(05 Mar 2000)
rheumatoid arthritis, systemic-onset juvenile Also known as systemic-onset juvenile chronic arthritis. Still's disease presents with systemic (bodywide) illness including high intermittent fever, a salmon-coloured skin rash, swollen lymph glands, enlargement of the liver and spleen, and inflammation of the lungs (pleuritis) and around the heart (pericarditis). The arthritis may not be immediately apparent but it does appear and may persist after the systemic symptoms are gone.
(12 Dec 1998)
perimuscular fibrosis Fibrosis in the outer media of arteries, usually the renal arteries of young women, where it causes segmental stenosis and hypertension; a variety of fibromuscular dysplasia.
Synonym: subadventitial fibrosis.
(05 Mar 2000)
pipestem fibrosis A characteristic pipe-shaped fibrosis formed around hepatic portal veins in some cases of long-continued heavy infection with Schistosoma mansoni; thought to be induced by the presence of large numbers of schistosome eggs in the hepatic tissues.
Synonym: Symmers' clay pipestem fibrosis, Symmers' fibrosis.
(05 Mar 2000)
congenital fibrosis of the extraocular muscles An autosomal dominant disorder associated with blepharoptosis and absence of eye movements.
(05 Mar 2000)
portal-systemic anastomoses Naturally-occurring venous communications between tributaries of the portal venous system and tributaries of the systemic venous system. The major portal-systemic anastomoses include: 1) oesophageal branches of left gastric vein with oesophageal veins, 2) superior rectal vein with middle and inferior rectal veins, 3) paraumbilical veins with subcutaneous veins of anterior abdominal wall, 4) retroperitoneal veins with venous branches of veins of the colon and bare area of the liver, and 5) a patent ductus venosus connecting left branch of portal vein to inferior vena cava (rare). These anastomoses are important clinically, providing collateral circulation during portal obstruction or hypertension, at which time they may become varicose.
See: caput medusae, oesophageal varices, haemorrhoids.
Surgically-created communications between the portal vein and the inferior vena cava or their tributaries, to relieve portal hypertension.
Synonym: portacaval anastomoses.
(05 Mar 2000)
portal-systemic encephalopathy An encephalopathy associated with cirrhosis of the liver, attributed to the passage of toxic nitrogenous substances from the portal to the systemic circulation; cerebral manifestations may include coma.
Synonym: hepatic encephalopathy.
(05 Mar 2000)
cystic fibrosis <chest medicine> A generalised disorder of infants, children and young adults, in which there is widespread dysfunction of the exocrine glands, characterised by signs of chronic pulmonary disease (due to excess mucus production in the respiratory tract), pancreatic deficiency, abnormally high levels of electrolytes in the sweat and occasionally by biliary cirrhosis. There is an ineffective immunologic defense against bacteria in the lungs.
Pathologically, the pancreas shows obstruction of the pancreatic ducts by amorphous eosinophilic concretions, with consequent deficiency of pancreatic enzymes, resulting in steatorrhoea and azotorrhoea and intestinal malabsorption. The degree of involvement of organs and glandular systems may vary greatly, with consequent variations in the clinical picture.
Inheritance: autosomal recessive.
(13 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • idiopathic
    Ư¹ß¼ºÀÇ;¾î¶² °³Àο¡ ƯÀ¯ÇÑ °íÀ¯ÀÇ
  • systemic
    °èÅëÀÇ
  • cystic fibrosis
    ³¶Æ÷¼º ¼¶À¯Áõ
  • fibrosis
    ¼¶À¯Áõ;¼¶À¯Çü¼º
  • systemic
    Á¶Á÷(°èÅë)ÀÇ;Àü½ÅÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á